Literature DB >> 256523

Piperacillin and carbenicillin; a collaborative in vitro comparison against 10,838 clinical bacterial isolates.

R N Jones, P C Fuchs, E H Gerlach, T L Gavan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 256523     DOI： 10.3949/ccjm.46.2.49

Source DB:  PubMed          Journal:  Cleve Clin Q        ISSN： 0009-8787


× No keyword cloud information.
  4 in total

Review 1.  Bacterial antibiotic resistance before and after clinical application in the United States.

Authors:  A L Barry; R N Jones
Journal:  Bull N Y Acad Med       Date:  1987-04

2.  Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.

Authors:  R N Jones; P C Fuchs; H M Sommers; T L Gavan; A L Barry; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

3.  Biliary concentrations of piperacillin in patients undergoing cholecystectomy.

Authors:  J A Giron; B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  Piperacillin pharmacokinetics in subjects with chronic renal failure.

Authors:  M I Thompson; M E Russo; J M Matsen; E Atkin-Thor
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.